Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide Maintenance in Elderly DLBCL
NCT01122472Phase 3Completed
- Sponsor
- LYSARC
- Start
- Apr 2009
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of lenalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by LYSARC. Started Apr 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01122472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122472.